Keyphrases
Systemic Lupus Erythematosus
100%
Lupus Nephritis
100%
Phoenix
100%
CD40 Ligand (CD40L)
50%
B Cells
37%
CD40
37%
Autoantibodies
25%
Cell-to-cell
25%
Kidney Cells
25%
Disease Activity
12%
Myeloid Cells
12%
Renal Tubular Epithelial Cells
12%
Kidney
12%
Inflammation
12%
Standard of Care
12%
Autoimmune Disease
12%
Platelet Activation
12%
T Cells
12%
Increased Incidence
12%
Monocytes
12%
Endothelial Cells
12%
Podocyte
12%
Therapeutic Intervention
12%
Kidney Biopsy
12%
Experimental Therapeutics
12%
Unmet Needs
12%
Thrombosis
12%
Mesangial Cells
12%
Dendritic Cells
12%
Immune Cells
12%
Glomerulus
12%
Non-hematopoietic Cells
12%
Preclinical Data
12%
Renal Interstitium
12%
Intervention Targets
12%
Tumor-infiltrating Immune Cells
12%
Safety Issues
12%
Unmet Medical Need
12%
Renal Injury
12%
Inflammatory Milieu
12%
Naïve B Cells
12%
Pathway-based Approach
12%
Interstitium
12%
Local Expansion
12%
Immunology and Microbiology
Systemic Lupus Erythematosus
100%
Lupus Erythematosus
100%
Nephritis
100%
CD40 Ligand
50%
B Cell
37%
Autoantibody
25%
Immunocompetent Cell
25%
Kidney Cell
25%
Interstitium
25%
Myeloid
12%
Autoimmune Disease
12%
Podocyte
12%
T Cell
12%
Hematopoietic Cell
12%
Thrombocyte Activation
12%
Dendritic Cell
12%
Glomerulus
12%
Naive B Cell
12%
Medicine and Dentistry
Systemic Lupus Erythematosus
100%
Lupus Nephritis
100%
B Cell
40%
CD40 Ligand
40%
Autoantibody
20%
Immunocompetent Cell
20%
Kidney Cell
20%
Interstitium
20%
Diseases
10%
Disease Activity
10%
Kidney Injury
10%
Myeloid Cell
10%
Autoimmune Disease
10%
Thrombocyte Activation
10%
Hematopoietic Cell
10%
Clinical Finding
10%
Renal Biopsy
10%
Endothelial Cell
10%
Epithelial Cell
10%
T Cell
10%
Dendritic Cell
10%
Thrombosis
10%
Glomerulus
10%
Podocyte
10%
Mesangial Cell
10%
Experimental Therapeutic
10%